Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Mallinckrodt
Dow
Johnson and Johnson
Boehringer Ingelheim

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

GRANISETRON HYDROCHLORIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Granisetron Hydrochloride patents expire, and when can generic versions of Granisetron Hydrochloride launch?

Granisetron Hydrochloride is a drug marketed by Akorn Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Bionpharma Inc, Cipla Ltd, Dr Reddys, Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Mylan Asi, Mylan Labs Ltd, Sandoz Inc, Teva Pharms Usa, West-ward Pharms Int, Wockhardt Usa, Apotex Inc, Barr, Chartwell Molecular, Dr Reddys Labs Ltd, Epic Pharma Llc, Mylan, Natco Pharma, Orchid Hlthcare, Taro, and Teva Pharms. and is included in forty-four NDAs.

The generic ingredient in GRANISETRON HYDROCHLORIDE is granisetron hydrochloride. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the granisetron hydrochloride profile page.

Drug patent expirations by year for GRANISETRON HYDROCHLORIDE
Recent Clinical Trials for GRANISETRON HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Alabama at BirminghamPhase 2
Heron TherapeuticsPhase 2
Northwell HealthPhase 1/Phase 2

See all GRANISETRON HYDROCHLORIDE clinical trials

Recent Litigation for GRANISETRON HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.2015-12-04
HELSINN HEALTHCARE S.A. v. HOSPIRA, INC.2015-03-23
HELSINN HEALTHCARE S.A. v. DR. REDDY'S LABORATORIES, LTD.2011-07-08

See all GRANISETRON HYDROCHLORIDE litigation

Pharmacology for GRANISETRON HYDROCHLORIDE
Synonyms for GRANISETRON HYDROCHLORIDE
007G998
007M998
1-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID (9-METHYL-9-AZA-BICYCLO[3.3.1]NON-3-YL)-AMIDE HYDROCHLORIDE
1-methyl-N-((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide hydrochloride
1-methyl-N-((1R,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide hydrochloride
1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide hydrochloride
1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1h-indazole-3-carboxamide hydrochloride(1:1)
1-METHYL-N-(9-METHYL-9-AZABICYCLO[3.3.1]NON-3-YL)-INDAZOLE-3-CARBOXAMIDE HCL
1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide hydrochloride
1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide hydrochloride
1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide hydrochloride
1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide monohydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide hydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide hydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide;hydrochloride
1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide hydrochloride
1044956-47-9
107007-99-8
109889-09-0 (Parent)
1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, monohydrochloride, endo-
1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-,monohydrochloride, endo-
318F6L70J8
A801552
AB0012545
AB0105685
AB2000059
AB53971
AC-478
AC1L22XJ
AC1OCEWF
AC1Q3DY9
AKOS015894931
AKOS025311206
ALM-101
AN-5268
API0002865
AS-12882
BC208011
BCP02186
BCP9000731
BEMA-Granisetron
BRL 43694A
BRL-43694A
C18H24N4O.HCl
CAS-107007-99-8
CCG-101117
CCG-213056
CHEBI:5538
CHEMBL1237080
CHEMBL1900758
CPD000469138
CS-1510
D00677
DSSTox_CID_28983
DSSTox_GSID_49057
DSSTox_RID_83248
DTXSID7049057
endo-1-Methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide hydrochloride
FT-0082684
FT-0626806
G0401
Granisertron hydrochloride
Granisetron (Hydrochloride)
Granisetron HCl
Granisetron hydrochloride (JAN/USAN)
Granisetron hydrochloride [USAN:USP]
Granisetron hydrochloride [USAN]
Granisetron hydrochloride preservative free
Granisetron hydrochloride, >=98% (HPLC), solid
Granisetron hydrochloride, European Pharmacopoeia (EP) Reference Standard
Granisetron Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Granisetron hydrochloride, United States Pharmacopeia (USP) Reference Standard
Granisetron Hydrocholride
Granisetron hydrocholride,(S)
Granisetron-MDTS
Granisol
HY-B0071A
I06-0077
I06-077
J-001688
Kytril
Kytril (TN)
Kytril Injection
LP01173
LS-81436
MCULE-2461768801
MFCD01747034
MLS001401373
MLS003915623
NC00367
NCGC00183873-01
NCGC00261858-01
NSC-672814
NSC-759839
NSC672814
NSC759839
Pharmakon1600-01502365
QYZRTBKYBJRGJB-UHFFFAOYSA-N
s1345
SAM001246527
Sancuso
SC-17029
SCHEMBL33433
SCHEMBL34177
SCHEMBL34179
SMR000469138
SMR001456513
SyB L-0701
TL8000249
Tox21_113607
Tox21_501173
UNII-318F6L70J8
W-5272
Paragraph IV (Patent) Challenges for GRANISETRON HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
KYTRIL INJECTABLE;INJECTION granisetron hydrochloride 020239 2007-03-08
KYTRIL INJECTABLE;INJECTION granisetron hydrochloride 020239 2004-07-19
KYTRIL INJECTABLE;INJECTION granisetron hydrochloride 020239 2004-06-01

US Patents and Regulatory Information for GRANISETRON HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc GRANISETRON HYDROCHLORIDE granisetron hydrochloride TABLET;ORAL 078843-001 Feb 27, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz Inc GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078835-002 Jun 30, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Taro GRANISETRON HYDROCHLORIDE granisetron hydrochloride TABLET;ORAL 090817-001 May 28, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Epic Pharma Llc GRANISETRON HYDROCHLORIDE granisetron hydrochloride TABLET;ORAL 078260-001 Dec 31, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms GRANISETRON HYDROCHLORIDE granisetron hydrochloride TABLET;ORAL 078080-001 Dec 31, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Colorcon
Mallinckrodt
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.